Hemodynamic Stability of Dexmedetomidine in Hypertensive Patients Undergoing Laparoscopic Cholecystectomy

• Status: Not yet recruiting
• Trial end date: 2021-03-02
• Target enrollment: 0
• Participant gender: All

Summary

Dexmedetomidine provides better hemodynamic stability to the patients with hypertension undergoing laparoscopic cholecystectomy.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dr. Ruth K.M. Pfau Civil Hospital, Karachi
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• Hypertensive patients of both genders of age 17 years to 70 years who are undergoing laparoscopic cholecystectomy.

• ASA II and III

Exclusion Criteria:

• Patients with a prior history of cardiac disease like ischemic heart disease, valvular disorders, undergone previous valve replacements, infective endocarditis and rheumatic fever.

• Renal diseases like acute kidney injury and chronic renal diseases.

• Endocrinal diseases like pheochromocytoma, hyperthyroidism, hypothyroidism, cushing disease etc.

• Pregnant and lactating females

• Short thick neck with anticipated difficult intubation

• Any sort of obstructive restrictive or reactive airway disease

• Patient allergic to any of the study medications.

• Obese patients (BMI>35)

• Narcotic addicts